Prosecution Insights
Prosecution Insights
Tech Center 3600 • Art Units: 3626 3683 3685 3686
This examiner grants 49% of resolved cases
John A. Pauls is an examiner in Tech Center 3600 and Art Unit 3626. He has managed 860 resolved cases, resulting in an allowance rate of 49.1%. This rate shows that 49.1% of the applications he reviews are granted. The median days to allowance for these cases is 1379, which indicates a longer prosecution timeline.
A notable aspect of his profile is the interview lift of 27.4%. This high lift suggests that conducting an interview is a very effective strategy for increasing the probability of an allowance. Practitioners should strongly consider requesting an interview to address any rejections or objections. With 860 resolved cases, the data is statistically significant and provides a reliable basis for planning. The 49.1% allowance rate combined with the 27.4% lift highlights the importance of proactive engagement in Art Unit 3626. Applicants should be prepared for a median duration of 1379 days when seeking a grant from this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18945759 | SYSTEMS AND METHODS FOR PATIENT TARGETED THERAPY DEVELOPMENT | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 18798670 | Information Management System and Method | Non-Final OA | CalmWave, Inc. |
| 18757553 | AUTONOMOUS MAINTENANCE MANAGEMENT OF A FACILITY | Non-Final OA | Honeywell International Inc. |
| 18705403 | METHOD PERFORMABLE WITH AN ELECTRONIC DEVICE IN ORDER TO COMMUNICATE WITH A DRUG DELIVERY DEVICE, ELECTRONIC DEVICE AND DRUG DELIVERY DEVICE | Non-Final OA | Sanofi |
| 19224303 | MACHINE LEARNING MODEL TRAINED USING ARTIFICIAL CELL-FREE RNA (CFRNA) EXPRESSION DATA | Non-Final OA | BostonGene Corporation |
| 18757823 | Methods and Systems for In-Clinic Compliance Protocols | Non-Final OA | IDEXX Laboratories, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy